−0.55 TWD
−40.05 M TWD
57.77 M TWD
36.47 M
About Vectorite Biomedical, Inc.
Sector
Industry
CEO
Ming Chang Ou
Website
Headquarters
New Taipei
Founded
2004
ISIN
TW0004170006
FIGI
BBG004DJJ790
Vectorite Biomedical, Inc. engages in the provision of immune cell storage, biotechnology service, and test service. Its business includes preparation sales, immune cell collection and storage, and medical intermediary. Its products and services include dendritic cell vaccine (DC vaccine), anti-malignant natural killer cell (NK cell) preparation, immune cell storage service, and cell preparation safety testing service. The company was founded on December 23, 2004 and is headquartered in New Taipei, Taiwan.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4170 is 14.35 TWD — it has increased by 2.17% in the past 24 hours. Watch Vectorite Biomedical, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange Vectorite Biomedical, Inc. stocks are traded under the ticker 4170.
4170 stock has risen by 1.43% compared to the previous week, the month change is a 17.43% rise, over the last year Vectorite Biomedical, Inc. has showed a −4.65% decrease.
4170 reached its all-time high on Jul 1, 2014 with the price of 84.35 TWD, and its all-time low was 5.40 TWD and was reached on Jul 21, 2020. View more price dynamics on 4170 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4170 stock is 3.57% volatile and has beta coefficient of 0.13. Track Vectorite Biomedical, Inc. stock price on the chart and check out the list of the most volatile stocks — is Vectorite Biomedical, Inc. there?
Today Vectorite Biomedical, Inc. has the market capitalization of 619.37 M, it has decreased by −3.87% over the last week.
Yes, you can track Vectorite Biomedical, Inc. financials in yearly and quarterly reports right on TradingView.
4170 net income for the last half-year is 3.83 M TWD, while the previous report showed −27.02 M TWD of net income which accounts for 114.16% change. Track more Vectorite Biomedical, Inc. financial stats to get the full picture.
No, 4170 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vectorite Biomedical, Inc. EBITDA is −9.55 M TWD, and current EBITDA margin is −29.79%. See more stats in Vectorite Biomedical, Inc. financial statements.
Like other stocks, 4170 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vectorite Biomedical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vectorite Biomedical, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vectorite Biomedical, Inc. stock shows the sell signal. See more of Vectorite Biomedical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.